Scatec Solar OL (0R3I)
London Exchange · UK · prices in NOK · close of 23 Oct 2026
Key indicators
| Last close | NOK 76.60 |
|---|---|
| 52-week range | 76.60 – 137.20 |
| Return, 1 month / 3 months | −23.5% / −21.1% |
| Return, 1 year / 3 years | −27.9% / +37.3% |
| Trend | Below its 200-day average |
| RSI (14) | 25 |
| Volatility (1 year) | 41.0% |
| Worst drawdown (1 year) | -43.1% |
| Average daily value traded | 5.69M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Scatec is a renewable energy company based in Norway that develops, builds, owns and operates solar power plants. It also works on hydropower and battery storage projects, and provides services across the life of these assets. Its customers and partners include governments, utilities and investors who need clean electricity, and its activities span several countries in emerging and developing markets as well as Europe.
The shares are listed on the London Exchange in UK under the code 0R3I, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Scatec Solar OL (0R3I) trades on the London Exchange in UK. It last closed at NOK 76.60 on 23 October 2026.
Its price-based Market X-Ray is 31 out of 100 (a weak price profile), ranking 3,055 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 27.9% and over the last three months it fell 21.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 17 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -28.5% | ||
| From 52-week high | -43.1% | ||
| Momentum | 19 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -21.1% | ||
| 6-month return | -36.5% | ||
| 12-month return, skipping the last month | -5.8% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.1% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 5.69M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −25.3% |
|---|---|
| 1 month | −23.5% |
| 3 months | −21.1% |
| 6 months | −36.5% |
| 1 year | −27.9% |
| 3 years | +37.3% |
| 5 years | −51.8% |
Signals
| 50-day / 200-day average | 98.77 / 107.07 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.83 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Apr 2023 | NOK 1.9400 |
| 29 Apr 2022 | NOK 2.5400 |
| 21 Apr 2021 | NOK 1.0900 |
| 22 Jul 2020 | NOK 0.9500 |
| 2 May 2019 | NOK 0.9500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.